The epigenome editors: How tools such as CRISPR offer new details about epigenetics
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Viral transduction for Cas9/sgRNA delivery in cell culture may cause accumulation of off-target mutations.
“| Delivery methods improvement | Application in cell culture [89–94] | Viral transduction | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [91]
Plasmid transfection for Cas9/sgRNA delivery in cell culture may cause accumulation of off-target mutations.
“| Delivery methods improvement | Application in cell culture [89–94] | Plasmid transfection | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [91]
RNP electroporation for Cas9/sgRNA delivery in cell culture eliminates off-target effects.
“| Delivery methods improvement | Application in cell culture [89–94] | RNP electroporation: Rapid transfection and turnover | Eliminate off-target effects |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [91]
Epigenetic editors could potentially exert off-target effects at the epigenome level.
“However, epigenetic editors could potentially exert off-target effects at the epigenome level”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Willyard, 2017
Epigenetic editors utilize enzymatically dead Cas9 (dCas9) to direct epigenetic modulation on targeted genes, thereby altering their endogenous expression level.
“These tools utilize enzymatically dead Cas9 (dCas9) to direct epigenetic modulation on targeted genes, thereby altering their endogenous expression level.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Willyard, 2017
CRISPR/Cas9-mediated off-target effects can also be reduced by epigenetic editors.
“In addition to base editors, CRISPR/Cas9-mediated off-target effects can also be reduced by epigenetic editors”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Willyard, 2017
Cites
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · see citing works
Hilton, I. B., D’Ippolito, A. M., Vockley, C. M., Thakore, P. I., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3199 · Cited by 1,879 · see citing works
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829 · see citing works
Brownell, J. E., Zhou, J., Ranalli, T. A., Kobayashi, R., Edmondson, D. G., Dent, S., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,636 · see citing works
Insulator dysfunction and oncogene activation in IDH mutant gliomas
Flavahan, W. A., Drier, Y., Liau, B. B., Gillespie, S. M., Venteicher, A. S., Stemmer-Rachamimov, A. O., Suvà, M. L., & Bernstein, B. E. (2016) · Nature · doi:10.1038/nature16490 · Cited by 1,288 · see citing works
Editing DNA Methylation in the Mammalian Genome
Liu, X. S., Wu, H., Ji, X., Stelzer, Y., Wu, X., Czauderna, S., Shu, J., Dadon, D., Young, R. A., & Jaenisch, R. (2016) · Cell · doi:10.1016/j.cell.2016.08.056 · Cited by 1,224 · see citing works
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
Wu, X., Scott, D. A., Kriz, A. J., Chiu, A. C., Hsu, P. D., Dadon, D. B., Cheng, A. W., Trevino, A. E., Konermann, S., Chen, S., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2889 · Cited by 944 · see citing works
Klann, T. S., Black, J. B., Chellappan, M., Safi, A., Song, L., Hilton, I. B., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3853 · Cited by 447 · see citing works
Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner
Cano-Rodríguez, D., Gjaltema, R. A. F., Jilderda, L. J., Jellema, P. G., Dokter‐Fokkens, J., Ruiters, M. H. J., & Rots, M. G. (2016) · Nature Communications · doi:10.1038/ncomms12284 · Cited by 276 · see citing works
Gene-Specific Targeting of H3K9 Methylation Is Sufficient for Initiating Repression In Vivo
Snowden, A. W., Gregory, P. D., Case, C. C., & Pabo, C. O. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01391-x · Cited by 268 · see citing works
Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors
Heller, E. A., Cates, H. M., Peña, C. J., Sun, H., Shao, N., Feng, J., Golden, S. A., Herman, J. P., Walsh, J. J., Mazei-Robison, M., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3871 · Cited by 227 · see citing works
CRISPR-mediated Activation of Latent HIV-1 Expression
Limsirichai, P., Gaj, T., & Schaffer, D. V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.213 · Cited by 109 · see citing works
Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells
Song, J., Cano-Rodríguez, D., Winkle, M., Gjaltema, R. A. F., Goubert, D., Jurkowski, T. P., Heijink, I. H., Rots, M. G., & Hylkema, M. N. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00059.2016 · Cited by 50 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Off-target effects in CRISPR/Cas9 gene editing
Guo, C., Ma, X., Gao, F., & Guo, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1143157 · Cited by 625 · see citing works
“However, epigenetic editors could potentially exert off-target effects at the epigenome level (Willyard, 2017), which should be carefully evaluated by ChIP-seq-based analysis.”
BackgroundCRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
Memi, F., Ntokou, A., & Papangeli, I. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.09.003 · Cited by 130 · see citing works
Tiane, A., Schepers, M., Riemens, R. J. M., Rombaut, B., Vandormael, P., Somers, V. A., Prickaerts, J., Hellings, N., van den Hove, D., & Vanmierlo, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03927-2 · Cited by 47 · see citing works
Analysis of DNA modifications in aging research
Masser, D. R., Hadad, N., Porter, H. L., Stout, M. B., Unnikrishnan, A., Stanford, D. R., & Freeman, W. M. (2018) · GeroScience · doi:10.1007/s11357-018-0005-3 · Cited by 37 · see citing works
Merlin, J. P. J., & Abrahamse, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117516 · Cited by 35 · see citing works
Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges
Pei, W., Zhang, Y., Yin, T., & Yu, Y. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz035 · Cited by 27 · see citing works
Blossom of CRISPR technologies and applications in disease treatment
Liu, H., Wang, L., & Luo, Y. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.10.003 · Cited by 19 · see citing works
Rethinking Parkinson's: The role of proteostasis networks and autophagy in disease progression
Sharma, A., Mannan, A., & Singh, T. G. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.104023 · Cited by 17 · see citing works
Vadigepalli, R., & Hoek, J. B. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13630 · Cited by 14 · see citing works
The future of pediatric gene therapy: CRISPR-Cas9, AI, and personalized medicine
Pan, Y., Ding, J., Wang, W., Xu, D., Fan, J., & Zhang, W. (2026) · Pediatric Research · doi:10.1038/s41390-026-05270-3 · Cited by 2 · see citing works
A review on Epigenome Editing using CRISPR-based Tools to Rejuvenate Skin Tissues
Sichani, A. S., Baneshi, M., Ranjbar, M., Naeimzadeh, Y., & Fallahi, J. (2023) · International Journal of Bioinformatics and Intelligent Computing · doi:10.61797/ijbic.v2i2.234 · Cited by 1 · see citing works
Waglawala, S. F., Singh, D. K., & Das, S. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-5646-4.ch014
- Authors
- Willyard, C.
- Corresponding author
- Willyard, Cassandra
- Venue
- Nature Medicine
- Published
- 2017-08
- Volume
- 23
- Issue
- 8
- Pages
- 900-903
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2744615298
- Cited by
- 13
- References
- 13
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2021: 1 · 2019: 1 · 2018: 4
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- epigenetics, epigenome editing, CRISPR, DNA methylation, transcriptional regulation, Id2, Id4
- MeSH terms
- Gene Editing, Humans, Epigenomics, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review